Jump to content
PayMap

CN1051451C抗艾滋病病毒药物组合物---青蒿素类药物,如青蒿琥酯等,是一种高效的抗艾滋病病毒药物|CN1051451C Anti-HIV drug combination---Artemisinin-based drugs, such as artemether, are highly effective anti-HIV drugs.


Roger

56 views

抗aids病毒的药物组合物

本发明涉及抗艾滋病毒的青蒿素类药物,例如青蒿琥酯等,是抗艾滋病毒的高效药物,毒性低,治疗指数大,安全可靠,价廉。青蒿素类药物是我国首创的药物,具有新型结构,本类药物原仅用于抗疟疾。因此本发明是使本类药在治疗艾滋病上有突破性的进展。

抗AIDS病毒的药物组合物

本发明涉及碳环化合物领域,特别涉及倍半萜内酯的青蒿素的衍生物二氢青蒿素苯氨基甲酸酯。
艾滋病是由艾滋病毒感染引起的一种传染性疾病导致人体免疫机能损伤性缺陷,它是一种世界性,致死性的传染性疾病。目前世界上约有2000万人感染了艾滋病毒,AIDS病期患者达600万,约有一半人已经死亡。我国也不例外,艾滋病已于1984年传入我国,目前我国已发现的HIV感染者890例,其中中国人带毒者740例,AIDS期病人5例,艾滋病者仍在不断地增加。
抗艾滋病毒药物,第一个被报导的是苏拉明(Suramin),1985年发现AZT(叠氮胸腺嘧啶脱养核苷)等具体抗艾滋病毒的活性,1986年进行了临床研究,1987年AZT作为第一个被美国FDA批准用于治疗艾滋病的药物。至今世界范围内筛选的有几百种新化合物及其配方,并包括几十种天然药物和中药。到目前为止,被美国FDA批准用于治疗艾滋病的药仅AZT、DDI(二脱氧肌苷)、DDC(二脱氧胞苷)、天然药物和中药中天花粉蛋白(GLQ23)被FDA批准进行临床观察,但是这几种药都存在着不同类型的毒性,如AZT应用4-6周后,病人出现骨髓抑制,继而发展成严重贫血,单独应用6个月后可产生耐药性,而且AZT并不能对巨噬细胞内感染的病毒有抑制作用,因而不能消除隐患,同时价格昂贵。DDC及DDI存在对外周神经的毒性,服药6周后即出现,应用较大剂量,既使停药一年仍然有后遗症。天花粉蛋白在临床试用中发现了神经毒,严重者出现一时性痴呆,甚至昏迷,实验研究表明天花粉蛋白处理感染HIV的巨噬细胞,产生和释放可溶性毒性物质,对人脑细胞有严重的破坏作用。
到目前为止在世界范围内被实验研究和评价的有几百种药物及其配方、天然药物、单味中药及复方中药中除很少数已分离了有效成分,如:日本报导甘草甜素、香菇多糖等,美国加州大学报导的紫花地丁有效成分等,而大多数均以粗提物进行实验,化合物中多为核苷,腺苷或肽类衍生物。及至1992年在荷兰阿姆斯特丹(Amsterdam)举办的世界艾滋病大会上,仍未见药物研究有突破性进展。
本发明目的在于:提供一种从中药中提取的化学有效成分及其衍生物,它们是毒性低、价廉的抗艾滋病类药物。克服AZT、DDI、DDC药物的缺点。本发明的另一个目的是用式I化合物制备抗AIDS病毒的组合物。本发明还有一个目的是用式I化合物或含淡化合物的药物治疗AIDS病的应用。
本发明的目的是这样达到的:采用了我国具有丰富资源的中药青蒿,即植物黄花蒿(Artemisia annua L..)中提取的青蒿素(artemisinin),进而合成二氢青蒿素苯氨基甲酸酯在抗艾滋病毒的作用上取得突破性进展,从而本发明目的就完全达到了即,本发明提供了如通式(I)的化合物...
 
 

 

Anti-AIDS-virus drug composition

The present invention relates to an artemisinin medicine for resisting AIDS viruses such as artesunate, etc., which is a high efficient medicine for resisting AIDS viruses. The present invention has the advantages of low toxicity, high therapeutic index, safety, reliability and low cost. The artemisinin medicine is firstly originated in China, and has a new structure. The artemisinin medicine is originally used for resisting malaria only, and therefore, the present invention makes a prominent progress for the medicine of curing AIDS.
 
The pharmaceutical composition of anti-AIDS-virus
The present invention relates to the carbocyclic compound field, particularly the derivative dihydro-abrotine phenyl urethan of the arteannuin of sesquiterpene lactones.
Acquired immune deficiency syndrome (AIDS) is to cause the damaging defective of human immunologic function by a kind of infectious disease that HIV (human immunodeficiency virus) infection causes, it is a kind of worldwide, the infectious disease of lethal.Have 2,000 ten thousand people to infect HIV (human immunodeficiency virus) at present in the world approximately, AIDS stadium patient reaches 6,000,000, has half people dead approximately.China was no exception, and acquired immune deficiency syndrome (AIDS) has been imported China in 1984, present HIV the infected's 890 examples of having found of China, and Chinese carrier's 740 examples wherein, AIDS phase patient 5 examples, the AIDS patient is still constantly increasing.
Anti-hiv drug, that first is reported is suramin (Suramin), found the activity of AZT concrete anti AIDS virus such as (Azidothymidine take off foster nucleoside) in 1985, carried out clinical research in 1986, AZT was used for the treatment of the medicine of acquired immune deficiency syndrome (AIDS) as first by drugs approved by FDA in 1987.So far in the world wide screening hundreds of kind noval chemical compound and prescription thereof arranged, and comprise tens kinds of natural drugs and Chinese medicine.Up to the present, the medicine that is used for the treatment of acquired immune deficiency syndrome (AIDS) by drugs approved by FDA trichosanthin (GLQ in AZT, DDI (didanosine), DDC (zalcitabine), natural drug and the Chinese medicine only 23) by FDA approval carrying out clinical observation, but these several medicines all exist dissimilar toxicity, use 4-6 after week as AZT, bone marrow depression appears in patient, then develop into serious anemia, can produce drug resistance after using 6 months separately, and AZT can not have inhibitory action to the virus that infects in the macrophage, thereby can not remove a hidden danger, cost an arm and a leg simultaneously.DDC and DDI exist peripheroneural toxicity, promptly occur after 6 weeks of taking medicine, and use heavy dose, have both made drug withdrawal that sequela was still arranged in 1 year.Trichosanthin has been found neural poison in clinic trial, momentary dementia appears in severe patient, even stupor, and experimentation shows the macrophage of trichosanthin processing infected by HIV, produce and release solubility toxicant, people's brain cell is had serious destruction.
Up to the present worldwide being removed seldom in hundreds of kind medicine and prescription, natural drug, single medicinal material and the herbal mixture by having of experimentation and evaluation, number has separated effective ingredient, as: Japan's report glycyrrhizin, lentinan etc., the Herba Violae effective ingredient of California, USA university report etc., and number average experimentizes with crude extract mostly, mostly be nucleoside in the chemical compound, adenosine or peptide derivative.And to 1992 in world's acquired immune deficiency syndrome (AIDS) conference that Amsterdam, the Netherlands (Amsterdam) is held, do not see that yet drug research has breakthrough.
The object of the invention is: a kind of chemical effective ingredient and derivant of extracting from Chinese medicine thereof is provided, and they are low, the inexpensive anti-AIDS class medicines of toxicity.Overcome the shortcoming of AZT, DDI, DDC medicine.Another object of the present invention is the compositions with formula I compound anti-AIDS-virus.A further object of the invention is with formula I chemical compound or contains the application of the Drug therapy AIDS disease of desalinating compound.
The objective of the invention is to reach like this: adopted China to have the Chinese medicine Herba Artemisiae Annuae of affluent resources, it is the arteannuin (artemisinin) that extracts in the plant Artemisia annua (Artemisia annua L..), and then synthesizing dihydro arteannuin phenyl urethan makes a breakthrough using of anti AIDS virus, thereby the object of the invention has just reached promptly fully, the invention provides the chemical compound as general formula (I)...
 

0 Comments


Recommended Comments

There are no comments to display.

Guest
Add a comment...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

Registration Terms & Conditions